LBA12 PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer.
Saved in:
| Title: | LBA12 PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer. |
|---|---|
| Authors: | Mayer, E.L.1 (AUTHOR), Gnant, M.I.2 (AUTHOR), DeMichele, A.3 (AUTHOR), Martin, M.4 (AUTHOR), Burstein, H.1 (AUTHOR), Prat, A.5 (AUTHOR), Rubovszky, G.6 (AUTHOR), Miller, K.D.7 (AUTHOR), Pfeiler, G.2 (AUTHOR), Winer, E.P.1 (AUTHOR), Zdenkowski, N.8 (AUTHOR), Anderson, D.9 (AUTHOR), Nowecki, Z.10 (AUTHOR), Loibl, S.11 (AUTHOR), Fohler, H.12 (AUTHOR), Metzger, O.1 (AUTHOR), Fumagalli, D.13 (AUTHOR), Puyana Theall, K.14 (AUTHOR), Fesl, C.15 (AUTHOR), Dueck, A.16 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS1145-S1145. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2020.08.2240 |
